- Home
- RPAY vs WHWK Comparison
RPAY vs WHWK Comparison
Compare RPAY & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPAY | WHWK |
|---|---|---|
| Founded | 2006 | 2007 |
| Country | United States | United States |
| Employees | N/A | 23 |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 223.5M | 197.2M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | RPAY | WHWK |
|---|---|---|
| Price | $3.31 | $4.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | $5.53 | ★ $7.50 |
| AVG Volume (30 Days) | ★ 1.6M | 182.6K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $309,261,000.00 | N/A |
| Revenue This Year | $12.54 | N/A |
| Revenue Next Year | $4.66 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.30 | $1.57 |
| 52 Week High | $5.90 | $4.40 |
Technical Indicators
Market Signals| Indicator | RPAY | WHWK |
|---|---|---|
| Relative Strength Index (RSI) | 45.95 | 71.50 |
| Support Level | $2.83 | $1.85 |
| Resistance Level | $3.87 | N/A |
| Average True Range (ATR) | 0.23 | 0.29 |
| MACD | -0.09 | 0.02 |
| Stochastic Oscillator | 9.24 | 88.89 |
Price Performance
Historical ComparisonAbout RPAY Repay Holdings Corporation
Repay Holdings Corp is a payments technology company. It provides integrated payment processing solutions to industry-oriented vertical markets in which businesses or other organizations have specific transaction processing needs. It allows customers to pay through Mobile App, Text, Interactive Voice Response, Virtual Terminal, Hosted Payment Page and Online Customer Portal among others. It operates in two segments Consumer Payments and Business Payments. The company generates majority of its revenue from Consumer Payments segment.
About WHWK Whitehawk Therapeutics Inc.
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.